Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | -2.41% | 55.85 | 6.5% | $169.16m | |
| CTLT | Catalent, Inc. | -0.72% | 77.45 | 2.1% | $112.22m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 1.22% | 17.40 | 14.1% | $102.38m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.99% | 105.55 | 2.4% | $76.64m | |
| UTHR | United Therapeutics Corp. | -1.27% | 115.95 | 14.3% | $67.46m | |
| BHC | Bausch Health Cos., Inc. | 1.22% | 17.40 | 0.0% | $65.42m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -4.35% | 43.13 | 16.8% | $62.97m | |
| PCRX | Pacira Biosciences, Inc. | -3.84% | 55.58 | 10.3% | $54.77m | |
| AXSM | Axsome Therapeutics, Inc. | -7.59% | 76.74 | 1.9% | $48.18m | |
| ZGNX | Zogenix, Inc. | -2.75% | 26.49 | 7.5% | $47.25m | |
| PRGO | Perrigo Co. Plc | 0.62% | 55.51 | 6.8% | $43.49m | |
| MYOK | MyoKardia, Inc. | -2.41% | 90.62 | 1.8% | $43.21m | |
| ARGX | argenx SE | 0.12% | 250.82 | 0.0% | $42.04m | |
| GWPH | GW Pharmaceuticals Plc | 3.35% | 132.19 | 6.2% | $41.23m | |
| ICLR | ICON plc | 1.08% | 171.79 | 4.3% | $37.33m |
Company Profile
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.